The metabolism of clopidogrel is regulated by the cytochrome P450 system (especially CYP2C19) and carriers of CYP2C19 LOF alleles had poor responses to clopidogrel in patients with acute minor stroke or TIA [9, 10]. This evidence concerns the gene CYP2C19 and transient ischemic attack.